Abstract | OBJECTIVES:
Botulinum neurotoxin serotype A ( BoNT/A) is a valid therapy for dystonia but repeated BoNT/A injections may induce a clinical immuno-resistance that could be overcome by using other BoNT serotypes. In vitro experiments and our preliminary investigations in vivo, indicate that botulinum neurotoxin serotype C (BoNT/C) could be an effective alternative to BoNT/A. Moreover, in cultured neurons 'in vitro' BoNT/C has been reported to be more toxic than BoNT/A. METHODS: To verify this possibility, we compare the effect of BoNT/C and BoNT/A on the motor units count in humans by using the electrophysiological motor unit number estimation (MUNE) technique ('multiple point nerve stimulation'). Preliminarily, BoNT/C and BoNT/A dosage was calibrated in a mouse hemidiaphragm neuromuscular junction preparation. Subsequently, 8 volunteers were treated with 3IU of BoNT/C in the extensor digitorum brevis muscle of one foot and 3IU of BoNT/A in the contralateral one. Other 4 subjects were similarly injected at higher doses (10IU of BoNT/C or BoNT/A) to detect a possible dose-toxic effect. RESULTS: In both groups, no statistically significant variations in MUNE counting or single motor unit potential size were detected after 4 months from injections, when it was evident a recovery from the BoNTs blockade. CONCLUSIONS: We conclude that BoNT/C, similarly to BoNT/A, is safe and effective in humans and it could be proposed for a clinical use.
|
Authors | Roberto Eleopra, Valeria Tugnoli, Rocco Quatrale, Ernesto Gastaldo, Ornella Rossetto, Domenico De Grandis, Cesare Montecucco |
Journal | Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
(Clin Neurophysiol)
Vol. 113
Issue 8
Pg. 1258-64
(Aug 2002)
ISSN: 1388-2457 [Print] Netherlands |
PMID | 12140005
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Neuromuscular Agents
- Botulinum Toxins
- Botulinum Toxins, Type A
- botulinum toxin type C
|
Topics |
- Animals
- Botulinum Toxins
(administration & dosage, pharmacology, therapeutic use)
- Botulinum Toxins, Type A
(administration & dosage, pharmacology, therapeutic use)
- Cell Count
- Cell Survival
- Cells, Cultured
- Dystonia
(drug therapy)
- Electric Stimulation
- Electrophysiology
- Hemifacial Spasm
(drug therapy)
- Humans
- Kinetics
- Male
- Mice
- Motor Neurons
(physiology)
- Neuromuscular Agents
(pharmacokinetics)
- Neuromuscular Junction
(physiology)
- Phrenic Nerve
(physiology)
|